Patent · US Active

Controlled release system for pulmonary delivery of surfactant protein D

US10682396B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignees

Inventors

Joseph Kost · Charleston, US
Tamar Traitel · Beer Sheva, IL
Riki Goldbart · Rahat, IL
Shani ATTIAS · Kiryat Motzkin, IL
Paul Scot KINGMA · Cincinnati, US
Jeffrey A. Whitsett · Cincinnati, US
Giora ENDEN · Nes Ziona, IL

Key dates

Filing date	Jun 9, 2016
Grant date	Jun 16, 2020
Priority date	—
Expiry date	Jun 9, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0043
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A controlled release system includes surfactant protein D (SPD) and a carrier suitable for controlled release that can be polylactic-co-glycolic acid (PLGA). The system can be in the form of a nanoparticle. A pharmaceutical composition includes the system and a pharmaceutically acceptable carrier. Methods of treatment of a disease, disorder or condition associated with a decreased level of SPD in a subject, or for pulmonary delivery of SPD, include administering the pharmaceutical composition to a subject in need of such treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.